Dr. Peter Marks sent a letter to acting FDA Commissioner Sara Brenner on Friday saying that he would resign and retire by April 5 as director of the Center for Biologics Evaluation and Research.

“He helped usher in scientific rigor and transparency into the FDA. And tonight, he is being pushed out,” Jha wrote on Friday. “Making the FDA dramatically weaker, less effective. This is ...

Dr. Peter Marks, a veteran official at the Food and Drug Administration (FDA) who helped establish the U.S. effort to rapidly develop Covid-19 vaccines, resigned on Friday. “It has become clear ...

The FDA’s top vaccine official, Dr. Peter Marks, abruptly resigned weeks after anti-vaccine activist Robert F. Kennedy took over as the head of Health and Humans Services. A person familiar with ...

The Wall Street Journal first reported news of Marks’ resignation. Both HHS and FDA did not respond to multiple requests by BioPharma Dive for comment. “I had the chance to work closely with ...

AP AUDIO: Top vaccine official resigns from FDA, criticizes RFK Jr. for promoting misinformation, lies AP correspondent Julie Walker reports the top vaccine official resigns from the FDA and ...

Kennedy Jr. Marks, who has served as the FDA's vaccine chief since 2016, resigned in a letter sent to acting FDA Commissioner Sara Brenner. In it, he alleged Kennedy is not interested in "truth ...

Dr. Peter Marks, who oversaw the FDA’s vaccine division as director of the Center for Biologics Evaluation and Research, submitted his resignation to acting FDA Commissioner Sara Brenner on Friday.

Dr. Peter Marks, who has served since 2016 as the director of the Center for Biologics Evaluation and Research (CBER) within the FDA, said in a letter to Acting FDA Commissioner Sara Benner that ...

Dr. Peter Marks sent a letter to Acting FDA Commissioner Sara Brenner on Friday saying that he would resign and retire by April 5 as director of the Center for Biologics Evaluation and Research.

Dr. Peter Marks sent a letter to Acting FDA Commissioner Sara Brenner on Friday saying that he would resign and retire by April 5 as director of the Center for Biologics Evaluation and Research.